Skip to main content

Advertisement

SpringerLink
Log in

Long-Term Urologic Evaluation Following Spinal Cord Injury

  • Voiding Dysfunction Evaluation (C Gomez, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Spinal cord injury (SCI) has significant long-term urologic consequences that impact quality of life (QOL) and can influence life expectancy. Neurogenic bladder, urinary tract infections, and autonomic dysreflexia are common consequences of SCI. It is essential to conduct a focused patient interview to address these consequences. History should include a basic assessment of the patient and symptomatology as per a validated instrument, as well as a detailed urologic diary. The physical examination should include evaluation of the extent of the neurologic injury as per the American Spinal Association Injury (ASIA) scale, the affected system as well as examination maneuvers done in those without neurologic injury. Investigations should include urodynamic testing and cystoscopy. In managing patients with SCI, pharmaceutical agents and intermittent catheterization are utilized normally in an effort to protect the upper urinary tract, achieve and maintain urinary continence, and optimize lower urinary tract function and quality of life (QOL).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. WHO. International perspectives in spinal cord injury. http://apps.who.int/iris/bitstream/10665/94190/1/9789241564663_eng.pdf. 2013.

  2. Hanson R. Spinal cord injury facts and statistics. http://sci-bc-database.ca/wp-content/uploads/SCI-Facts-and-Stats-2005.pdf. 2005.

  3. Noonan VK, Fingas M, Farry A, et al. Incidence and prevalence of spinal cord injury in Canada: a national perspective. Neuroepidemiology. 2012;38:219–26.

    Article  PubMed  Google Scholar 

  4. Middleton JW, Dayton A, Walsh J, Rutkowski SB, Leong G, Duong S. Life expectancy after spinal cord injury: a 50-year study. Spinal Cord. 2012;50:803–11.

    Article  CAS  PubMed  Google Scholar 

  5. New PW, Sundararajan V. Incidence of non-traumatic spinal cord injury in Victoria, Australia: a population-based study and literature review. Spinal Cord. 2008;46:406–11.

    Article  CAS  PubMed  Google Scholar 

  6. Noreau L, Noonan VK, Cobb J, Leblond J, Dumont FS. Spinal cord injury community survey: understanding the needs of Canadians with SCI. Top Spinal Cord Inj Rehabil. 2014;20:265–76.

    Article  PubMed  PubMed Central  Google Scholar 

  7. American Spinal Association Injury. ASIA international standards for neurological classification of spinal cord injury. http://www.asia-spinalinjury.org. 2015. Use of the ASIA score amongst all clinical caregivers will facilitate the management and research strategies focused on the care of those with spinal cord injury. The document outlines the core principals required to establish an ASIA score in a patient.

  8. Noreau L. SCI community survey. Rick Hansen Institute. 2015

  9. Devivo M. Costs of care following spinal cord injury. Top Spinal Cord Inj Rehabil. 2011;16:1.

    Article  Google Scholar 

  10. Cao Y. Lifetime direct costs after spinal cord injury. Top Spinal Cord Inj Rehabil. 2011;16:10.

    Article  Google Scholar 

  11. Munce SE, Wodchis WP, Guilcher SJ, et al. Direct costs of adult traumatic spinal cord injury in Ontario. Spinal Cord. 2013;51:64–9.

    Article  CAS  PubMed  Google Scholar 

  12. Haeusler JM, Tobler B, Arnet B, Huesler J, Zimmermann H. Pilot study on the comprehensive economic costs of major trauma: consequential costs are well in excess of medical costs. J Trauma. 2006;61:723–31.

    PubMed  Google Scholar 

  13. Krueger H, Noonan VK, Trenaman LM, Joshi P, Rivers CS. The economic burden of traumatic spinal cord injury in Canada. Chronic Dis Inj Can. 2013;33:113–22.

    CAS  PubMed  Google Scholar 

  14. Norrbrink Budh C, Kowalski J, Lundeberg T. A comprehensive pain management programme comprising educational, cognitive and behavioural interventions for neuropathic pain following spinal cord injury. J Rehabil Med. 2006;38:172–80.

    Article  PubMed  Google Scholar 

  15. McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil. 1999;80:1402–10.

    Article  CAS  PubMed  Google Scholar 

  16. Albright TH, Grabel Z, DePasse JM, Palumbo MA, Daniels AH. Sexual and reproductive function in spinal cord injury and spinal surgery patients. Orthop Rev (Pavia). 2015;7:5842.

    Article  Google Scholar 

  17. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010;48:718–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Byrne DW, Salzberg CA. Major risk factors for pressure ulcers in the spinal cord disabled: a literature review. Spinal Cord. 1996;34:255–63.

    Article  CAS  PubMed  Google Scholar 

  19. Barclay L, McDonald R, Lentin P, Bourke-Taylor H. Facilitators and barriers to social and community participation following spinal cord injury. Aust Occup Ther J. 2015.

  20. Andresen EM, Fouts BS, Romeis JC, Brownson CA. Performance of health-related quality-of-life instruments in a spinal cord injured population. Arch Phys Med Rehabil. 1999;80:877–84.

    Article  CAS  PubMed  Google Scholar 

  21. Lundqvist C, Siosteen A, Sullivan L, Blomstrand C, Lind B, Sullivan M. Spinal cord injuries: a shortened measure of function and mood. Spinal Cord. 1997;35:17–21.

    Article  CAS  PubMed  Google Scholar 

  22. Noreau L, Cobb J, Belanger LM, Dvorak MF, Leblond J, Noonan VK. Development and assessment of a community follow-up questionnaire for the Rick Hansen spinal cord injury registry. Arch Phys Med Rehabil. 2013;94:1753–65.

    Article  PubMed  Google Scholar 

  23. Fonte N. Urological care of the spinal cord-injured patient. J Wound Ostomy Continence Nurs. 2008;35:323–31. quiz 332–3.

    Article  PubMed  Google Scholar 

  24. Garcia Leoni ME, Esclarin De Ruz A. Management of urinary tract infection in patients with spinal cord injuries. Clin Microbiol Infect. 2003;9:780–5.

    Article  CAS  PubMed  Google Scholar 

  25. Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med. 2006;29: 527–573.

  26. Stover SL, Lloyd LK, Waites KB, Jackson AB. Urinary tract infection in spinal cord injury. Arch Phys Med Rehabil. 1989;70:47–54.

    CAS  PubMed  Google Scholar 

  27. Taweel WA, Seyam R. Neurogenic bladder in spinal cord injury patients. Res Rep Urol. 2015;7:85–99.

    PubMed  PubMed Central  Google Scholar 

  28. Krassioukov A, Eng JJ, Warburton DE, Teasell R, Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of orthostatic hypotension after spinal cord injury. Arch Phys Med Rehabil. 2009;90:876–85.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Middleton JW. Management of the neurogenic bladder for adults with spinal cord injuries. Agency Clin Innov. 2014.

  30. Shingleton WB, Bodner DR. The development of urologic complications in relationship to bladder pressure in spinal cord injured patients. J Am Paraplegia Soc. 1993;16:14–7.

    CAS  PubMed  Google Scholar 

  31. Noreau L, Noonan VK, Cobb J, Leblond J, Dumont FS. Spinal cord injury community survey: a national, comprehensive study to portray the lives of Canadians with spinal cord injury. Top Spinal Cord Inj Rehabil. 2014;20:249–64.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cardenas DD, Hoffman JM, Kelly E, Mayo ME. Impact of a urinary tract infection educational program in persons with spinal cord injury. J Spinal Cord Med. 2004;27:47–54.

    PubMed  Google Scholar 

  33. Everaert K, Lumen N, Kerckhaert W, Willaert P, van Driel M. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg. 2009;64:335–40.

    Article  CAS  PubMed  Google Scholar 

  34. Consortium for Spinal Cord Medicine. Autonomic dysreflexia: what you should know. Paralyzed Veterans of America. 1997.

  35. Duggan C. Quality of life after spinal cord injury: a qualitative study. Rehabil Psychol. 2001;46:3.

    Article  Google Scholar 

  36. Tsang B, Stothers L, Macnab A, Lazare D, Nigro M. A systematic review and comparison of questionnaires in the management of spinal cord injury, multiple sclerosis and the neurogenic bladder. Neurourol Urodyn. 2015

  37. Land NE, Odding E, Duivenvoorden HJ, Bergen MP, Stam HJ. Tetraplegia hand activity questionnaire (THAQ): the development, assessment of arm-hand function-related activities in tetraplegic patients with a spinal cord injury. Spinal Cord. 2004;42:294–301.

    Article  CAS  PubMed  Google Scholar 

  38. Franceschini M, Di Clemente B, Citterio A, Pagliacci MC. Follow-up in persons with traumatic spinal cord injury: questionnaire reliability. Eura Medicophys. 2006;42:211–8.

    CAS  PubMed  Google Scholar 

  39. Bonniaud V, Bryant D, Parratte B, Guyatt G. Development and validation of the short form of a urinary quality of life questionnaire: SF-Qualiveen. J Urol. 2008;180:2592–8.

    Article  PubMed  Google Scholar 

  40. Bors E, Turner RD. History and physical examination in neurological urology. J Urol. 1960;83:759–67.

    CAS  PubMed  Google Scholar 

  41. Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: report of the Standardization Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–98. Terminology related to lower urinary tract symptoms is critical in communication and research strategies for the management of neurogenic bladder. The International Continence Society terminology reflects changes in medical practice. New terminology is defined and older terminology is identified.

    Article  PubMed  Google Scholar 

  42. L Stothers, B Tsang, M Nigro, D Lazare, A Macnab. An integrative review of standardized clinical evaluation tool utilization in anticholinergic drug trials for neurogenic lower urinary tract dysfunction. Spinal Cord. 2016; In press.

  43. Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic organ prolapse quantification system (POP-Q)—a new era in pelvic prolapse staging. J Med Life. 2011;4:75–81.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Pannek J, Blok B, Castro Diaz D et al. European Association of Urology (EAU) Guidelines; Neurogenic Lower Urinary Tract Dysfunction. 2013. The EAU Guidelines on neurogenic bladder diagnosis and management provides a comprehensive framework from which clinical decision making can be made related to neurogenic bladder. The document includes critical review of therapeutic options from the lens of best practices related to optimal therapy in those with spinal cord injury and other associated neurologic condition.

  45. Collins CW, Winters JC. American Urological Association, Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction. AUA/SUFU adult urodynamics guideline: a clinical review. Urol Clin N Am. 2014;41:353–62. vii.

    Article  Google Scholar 

  46. Madersbacher H. The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia. 1990;28:217–29.

    Article  CAS  PubMed  Google Scholar 

  47. Sammer U, Walter M, Knupfer SC, Mehnert U, Bode-Lesniewska B, Kessler TM. Do we need surveillance urethro-cystoscopy in patients with neurogenic lower urinary tract dysfunction? PLoS One. 2015;10, e0140970.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol. 2012;62:816–30.

    Article  CAS  PubMed  Google Scholar 

  49. Kanai A, Zabbarova I, Oefelein M, Radziszewski P, Ikeda Y, Andersson KE. Mechanisms of action of botulinum neurotoxins, beta3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011. Neurourol Urodyn. 2012;31:300–8.

    Article  CAS  PubMed  Google Scholar 

  50. del Popolo G, Mencarini M, Nelli F, Lazzeri M. Controversy over the pharmacological treatments of storage symptoms in spinal cord injury patients: a literature overview. Spinal Cord. 2012;50:8–13.

    Article  PubMed  Google Scholar 

  51. Amend B, Hennenlotter J, Schafer T, Horstmann M, Stenzl A, Sievert KD. Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects. Eur Urol. 2008;53:1021–8.

    Article  CAS  PubMed  Google Scholar 

  52. Bennett N, O'Leary M, Patel AS, Xavier M, Erickson JR, Chancellor MB. Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol. 2004;171:749–51.

    Article  CAS  PubMed  Google Scholar 

  53. Igawa Y, Aizawa N, Homma Y. Beta3-adrenoceptor agonists: possible role in the treatment of overactive bladder. Korean J Urol. 2010;51:811–8.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Andersson KE, Martin N, Nitti V. Selective beta(3)-adrenoceptor agonists for the treatment of overactive bladder. J Urol. 2013;190:1173–80.

    Article  CAS  PubMed  Google Scholar 

  55. Rossanese M, Novara G, Challacombe B, Iannetti A, Dasgupta P, Ficarra V. Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a beta(3)-adrenoceptor agonist (mirabegron) for overactive bladder (OAB). BJU Int. 2015;115:32–40.

    Article  CAS  PubMed  Google Scholar 

  56. Apostolidis A. Taming the cannabinoids: new potential in the pharmacologic control of lower urinary tract dysfunction. Eur Urol. 2012;61:107–9. discussion 109–11.

    Article  PubMed  Google Scholar 

  57. Abrams P, Amarenco G, Bakke A, et al. Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol. 2003;170:1242–51.

    Article  PubMed  Google Scholar 

  58. Reid G, Hsiehl J, Potter P, et al. Cranberry juice consumption may reduce biofilms on uroepithelial cells: pilot study in spinal cord injured patients. Spinal Cord. 2001;39:26–30.

    Article  CAS  PubMed  Google Scholar 

  59. Opperman EA. Cranberry is not effective for the prevention or treatment of urinary tract infections in individuals with spinal cord injury. Spinal Cord. 2010;48:451–6.

    Article  CAS  PubMed  Google Scholar 

  60. Matlaga BR, Kim SC, Watkins SL, Kuo RL, Munch LC, Lingeman JE. Changing composition of renal calculi in patients with neurogenic bladder. J Urol. 2006;175:1716–9. discussion 1719.

    Article  PubMed  Google Scholar 

  61. Shenot P, Rivas DA, Kalman DD, Staas Jr WE, Chancellor MB. Latex allergy manifested in urological surgery and care of adult spinal cord injured patients. Arch Phys Med Rehabil. 1994;75:1263–5.

    Article  CAS  PubMed  Google Scholar 

  62. Prieto J, Murphy CL, Moore KN, Fader M. Intermittent catheterisation for long-term bladder management. Cochrane Database Syst Rev. 2014;9, CD006008.

    PubMed  Google Scholar 

  63. Wyndaele JJ, Brauner A, Geerlings SE, Bela K, Peter T, Bjerklund-Johanson TE. Clean intermittent catheterization and urinary tract infection: review and guide for future research. BJU Int. 2012;110:E910–7.

    Article  PubMed  Google Scholar 

  64. Barber DB, Woodard FL, Rogers SJ, Able AC. The efficacy of nursing education as an intervention in the treatment of recurrent urinary tract infections in individuals with spinal cord injury. SCI Nurs. 1999;16:54–6.

    CAS  PubMed  Google Scholar 

  65. Ho M, Stothers L, Lazare D, Tsang B, Macnab A. Evaluation of educational content of YouTube videos relating to neurogenic bladder and intermittent catheterization. Can Urol Assoc J. 2015;9:320–54.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Cruz F, Herschorn S, Aliotta P, et al. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial. Eur Urol. 2011;60:742–50.

    Article  CAS  PubMed  Google Scholar 

  67. Ginsberg D, Gousse A, Keppenne V, et al. Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity. J Urol. 2012;187:2131–9.

    Article  CAS  PubMed  Google Scholar 

  68. Duthie JB, Vincent M, Herbison GP, Wilson DI, Wilson D. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev. 2011;(12):CD005493. doi: CD005493.

  69. Utomo E, Groen J, Blok BF. Surgical management of functional bladder outlet obstruction in adults with neurogenic bladder dysfunction. Cochrane Database Syst Rev. 2014;5, CD004927.

    PubMed  Google Scholar 

  70. Noll F, Sauerwein D, Stohrer M. Transurethral sphincterotomy in quadriplegic patients: long-term-follow-up. Neurourol Urodyn. 1995;14:351–8.

    Article  CAS  PubMed  Google Scholar 

  71. Perkash I. Use of contact laser crystal tip firing nd:YAG to relieve urinary outflow obstruction in male neurogenic bladder patients. J Clin Laser Med Surg. 1998;16:33–8.

    CAS  PubMed  Google Scholar 

  72. Castro-Diaz D, Barrett D, Grise P. Surgery for the neuropathic patient. Incontinence; Plymouth Health Publ. 2002;2:865.

    Google Scholar 

  73. Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol. 2010;58:865–74.

    Article  PubMed  Google Scholar 

  74. Salameh A, Al Mohajer M, Daroucihe RO. Prevention of urinary tract infections in patients with spinal cord injury. CMAJ. 2015;187:807–11.

    Article  PubMed  Google Scholar 

  75. Chancellor MB, Rivas DA, Liberman SN, Moore Jr J, Staas Jr WE. Cystoscopic autogenous fat injection treatment of vesicoureteral reflux in spinal cord injury. J Am Paraplegia Soc. 1994;17:50–4.

    CAS  PubMed  Google Scholar 

  76. Wan D, Krassioukov AV. Life-threatening outcomes associated with autonomic dysreflexia: a clinical review. J Spinal Cord Med. 2014;37:2–10.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Liu N, Zhou M, Biering-Sorensen F, Krassioukov AV. Iatrogenic urological triggers of autonomic dysreflexia: a systematic review. Spinal Cord. 2015;53:500–9.

    Article  CAS  PubMed  Google Scholar 

  78. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692–7.

    Article  CAS  PubMed  Google Scholar 

  79. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1988;139:919–22.

    CAS  PubMed  Google Scholar 

  80. Igawa Y, Satoh T, Mizusawa H, et al. The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury. BJU Int. 2003;91:637–41.

    Article  CAS  PubMed  Google Scholar 

  81. Vaidyanathan S, Soni BM, Sett P, Watt JW, Oo T, Bingley J. Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodes. Spinal Cord. 1998;36:761–70.

    Article  CAS  PubMed  Google Scholar 

  82. Swierzewski 3rd SJ, Gormley EA, Belville WD, Sweetser PM, Wan J, McGuire EJ. The effect of terazosin on bladder function in the spinal cord injured patient. J Urol. 1994;151:951–4.

    PubMed  Google Scholar 

  83. Chancellor MB, Erhard MJ, Hirsch IH, Stass Jr WE. Prospective evaluation of terazosin for the treatment of autonomic dysreflexia. J Urol. 1994;151:111–3.

    CAS  PubMed  Google Scholar 

  84. Esmail Z, Shalansky KF, Sunderji R, Anton H, Chambers K, Fish W. Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. Arch Phys Med Rehabil. 2002;83:604–8.

    Article  PubMed  Google Scholar 

  85. Frost F. Antihypertensive therapy, nifedipine, and autonomic dysreflexia. Arch Phys Med Rehabil. 2002;83:1325–6. author reply 1326.

    Article  PubMed  Google Scholar 

  86. Krassioukov A, Warburton DE, Teasell R, Eng JJ, Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch Phys Med Rehabil. 2009;90:682–95.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Steinberger RE, Ohl DA, Bennett CJ, McCabe M, Wang SC. Nifedipine pretreatment for autonomic dysreflexia during electroejaculation. Urology. 1990;36:228–31.

    Article  CAS  PubMed  Google Scholar 

  88. Thyberg M, Ertzgaard P, Gylling M, Granerus G. Effect of nifedipine on cystometry-induced elevation of blood pressure in patients with a reflex urinary bladder after a high level spinal cord injury. Paraplegia. 1994;32:308–13.

    Article  CAS  PubMed  Google Scholar 

  89. Ghidini A, Healey A, Andreani M, Simonson MR. Pregnancy and women with spinal cord injuries. Acta Obstet Gynecol Scand. 2008;87:1006–10.

    Article  PubMed  Google Scholar 

  90. Bertschy S, Geyh S, Pannek J, Meyer T. Perceived needs and experiences with healthcare services of women with spinal cord injury during pregnancy and childbirth—a qualitative content analysis of focus groups and individual interviews. BMC Health Serv Res. 2015;15: 234-015-0878-0.

  91. Bertschy S, Bostan C, Meyer T, Pannek J. Medical complications during pregnancy and childbirth in women with SCI in Switzerland. Spinal Cord. 2015.

  92. Galusca N, Charvier K, Courtois F, Rode G, Rudigoz RC, Ruffion A. Antibioprophylaxy and urological management of women with spinal cord injury during pregnancy. Prog Urol. 2015;25:489–96.

    Article  CAS  PubMed  Google Scholar 

  93. Kalpakjian CZ, Quint EH, Bushnik T, Rodriguez GM, Terrill MS. Menopause characteristics and subjective symptoms in women with and without spinal cord injury. Arch Phys Med Rehabil. 2010;91:562–9.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Dannels A, Charlifue S. The perimenopause experience for women with spinal cord injuries. SCI Nurs. 2004;21:9–13.

    PubMed  Google Scholar 

  95. Courtois F, Charvier K. Sexual dysfunction in patients with spinal cord lesions. Handb Clin Neurol. 2015;130:225–45.

    Article  PubMed  Google Scholar 

  96. Derry F, Hultling C, Seftel AD, Sipski ML. Efficacy and safety of sildenafil citrate (viagra) in men with erectile dysfunction and spinal cord injury: a review. Urology. 2002;60:49–57.

    Article  PubMed  Google Scholar 

  97. Saenz de Tejada I, Angulo J, Cellek S, et al. Physiology of erectile function. J Sex Med. 2004;1:254–65.

    Article  CAS  PubMed  Google Scholar 

  98. Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med. 2012;9:970–85.

    Article  CAS  PubMed  Google Scholar 

  99. Bodner DR, Haas CA, Krueger B, Seftel AD. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology. 1999;53:199–202.

    Article  CAS  PubMed  Google Scholar 

  100. Bella AJ, Brock GB. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine. 2004;23:149–55.

    Article  CAS  PubMed  Google Scholar 

  101. Levine LA. External devices for treatment of erectile dysfunction. Endocrine. 2004;23:157–60.

    Article  CAS  PubMed  Google Scholar 

  102. Zermann DH, Kutzenberger J, Sauerwein D, Schubert J, Loeffler U. Penile prosthetic surgery in neurologically impaired patients: long-term followup. J Urol. 2006;175:1041–4. discussion 1044.

    Article  PubMed  Google Scholar 

  103. Teng YD, Lavik EB, Qu X, et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A. 2002;99:3024–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Novikova LN, Novikov LN, Kellerth JO. Biopolymers and biodegradable smart implants for tissue regeneration after spinal cord injury. Curr Opin Neurol. 2003;16:711–5.

    Article  CAS  PubMed  Google Scholar 

  105. Hartigan C, Kandilakis C, Dalley S, et al. Mobility outcomes following five training sessions with a powered exoskeleton. Top Spinal Cord Inj Rehabil. 2015;21:93–9.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Benson I, Hart K, Tussler D, van Middendorp JJ. Lower-limb exoskeletons for individuals with chronic spinal cord injury: findings from a feasibility study. Clin Rehabil. 2016;30:73–84.

    Article  PubMed  Google Scholar 

  107. Wirz M, Zemon DH, Rupp R, et al. Effectiveness of automated locomotor training in patients with chronic incomplete spinal cord injury: a multicenter trial. Arch Phys Med Rehabil. 2005;86:672–80.

    Article  PubMed  Google Scholar 

  108. Esquenazi A, Talaty M, Packel A, Saulino M. The ReWalk powered exoskeleton to restore ambulatory function to individuals with thoracic-level motor-complete spinal cord injury. Am J Phys Med Rehabil. 2012;91:911–21.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. International Collaboration on Repair Discoveries (ICORD), Faculty of Medicine, University of British Columbia, 818 W. 10th Avenue, Vancouver, BC V5Z, Canada

    Lynn Stothers & Mark Nigro

  2. Department of Urologic Sciences, Gordon and Leslie Diamond Health Care Centre, University of British Columbia, Level 6, 2775 Laurel Street, Vancouver, BC V5Z, Canada

    Lynn Stothers, Jennifer A. Locke, Andrew Macnab & Mark Nigro

  3. Department of Obstetrics and Gynaecology, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada

    Lynn Stothers

Authors
  1. Lynn Stothers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer A. Locke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew Macnab
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark Nigro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lynn Stothers.

Ethics declarations

Conflict of Interest

Drs Stothers, Locke, Macnab, and Nigro declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Voiding Dysfunction Evaluation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stothers, L., Locke, J.A., Macnab, A. et al. Long-Term Urologic Evaluation Following Spinal Cord Injury. Curr Bladder Dysfunct Rep 11, 169–180 (2016). https://doi.org/10.1007/s11884-016-0367-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0367-2

Keywords

Search

Navigation